Biotech for rare immune diseases
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 80 | New buy | 41,072 | $191,806 | 0.0% |
| Andrew Law / Caxton | 66 | Holds (flat) | 15,557 | $72,650 | 3.9% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.